利用 CRISPR 基因编辑技术优化 CAR-T 细胞疗法的疗效、安全性与可及性

Chimeric Antigen Receptor (CAR)-T-cell therapy has revolutionized cancer immune therapy.

However, challenges remain including increasing efficacy, reducing adverse events and increasing accessibility. Use of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology can effectively perform various functions such as precise integration, multi-gene editing, and genome-wide functional regulation.

Additionally, CRISPR screening using large-scale guide RNA (gRNA) genetic perturbation provides an unbiased approach to understanding mechanisms underlying anti-cancer efficacy of CAR T-cells. Several emerging CRISPR tools with high specificity, controllability and efficiency are useful to modify CAR T-cells and identify new targets. In this review we summarize potential uses of the CRISPR system to improve results of CAR T-cells therapy including optimizing efficacy and safety and, developing universal CAR T-cells.

We discuss challenges facing CRISPR gene editing and propose solutions highlighting future research directions in CAR T-cell therapy.